Suppr超能文献

红参提取物中的过敏原会诱导与类过敏反应相关的介质释放。

Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions.

作者信息

Wang Lu, Zhao Yazheng, Yang Ye, Hu Yuanjia, Zou Xiaohan, Yu Boyang, Qi Jin

机构信息

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing, China.

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.

出版信息

J Transl Med. 2017 Jun 28;15(1):148. doi: 10.1186/s12967-017-1249-x.

Abstract

BACKGROUND

Anaphylactoid reactions induced by preparations containing red ginseng have been reported. The aim of this study is to evaluate the allergenicity and screen potential allergens in red ginseng extract thoroughly.

METHODS

Red ginseng extract (RGE) and different fractions of RGE were prepared and evaluated by measuring the degranulation and viability of rat basophilic leukemia 2H3 (RBL-2H3) cells. Potential allergens were screened by RBL-2H3 cell extraction and allergenicity verified in RBL-2H3 cells, mouse peritoneal mast cells, Laboratory of Allergic Disease 2 (LAD2) human mast cells and mice, respectively.

RESULTS

80% ethanol extract of red ginseng extract induced mast cell degranulation with less cytotoxicity, but 40% ethanol extract could not. Ginsenoside Rd and 20(S)-Rg3 could induce a significant increase in β-hexosaminidase release, histamine release and translocation of phosphatidylserine in RBL-2H3 cells. Ginsenoside Rd and 20(S)-Rg3 also increased β-hexosaminidase release and the intracellular Ca concentration in mouse peritoneal mast cells and LAD2 cells. In addition, histamine levels in serum of mice were elevated dose-dependently.

CONCLUSIONS

Ginsenoside Rd and 20(S)-Rg3 are potential allergens that induce the release of mediators associated with anaphylactoid reactions. Our study could guide optimization of methods associated with Rd/20(S)-Rg3-containing preparations and establishment of quality standards for safe application of Traditional Chinese Medicines.

摘要

背景

已有含红参制剂引起类过敏反应的报道。本研究旨在全面评估红参提取物的致敏性并筛选潜在过敏原。

方法

制备红参提取物(RGE)及其不同组分,通过检测大鼠嗜碱性白血病2H3(RBL-2H3)细胞的脱颗粒和活力进行评估。通过RBL-2H3细胞提取筛选潜在过敏原,并分别在RBL-2H3细胞、小鼠腹腔肥大细胞、变应性疾病实验室2(LAD2)人肥大细胞和小鼠中验证其致敏性。

结果

红参提取物的80%乙醇提取物可诱导肥大细胞脱颗粒,细胞毒性较小,但40%乙醇提取物则不能。人参皂苷Rd和20(S)-Rg3可诱导RBL-2H3细胞中β-己糖胺酶释放、组胺释放及磷脂酰丝氨酸转位显著增加。人参皂苷Rd和20(S)-Rg3还可增加小鼠腹腔肥大细胞和LAD2细胞中β-己糖胺酶释放及细胞内钙浓度。此外,小鼠血清中的组胺水平呈剂量依赖性升高。

结论

人参皂苷Rd和20(S)-Rg3是诱导类过敏反应相关介质释放的潜在过敏原。我们的研究可为含Rd/20(S)-Rg3制剂相关方法的优化及中药安全应用质量标准的建立提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf9/5490175/e40b08f4c928/12967_2017_1249_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验